Palbociclib Shows Promising Survival Results in Black Patients with Advanced Breast Cancer
April 7th 2023While results of the PALOMA-2 study did not show a survival benefit for the overall population on the combination of palbociclib and letrozole but did show an overall survival benefit in Black patients on the combination therapy.
RWD Show Survival Advantage of Frontline Letrozole Plus Palbociclib in Minorities With aBC
January 18th 2023Adam Brufsky, MD, PhD, FACP, discusses the real-world efficacy of letrozole in combination with palbociclib as treatment of patients with estrogen receptor-positive, HER2-negative, advanced breast cancer, based on race and ethnicity.